Astrana Health Inc.

NASDAQ: ASTH · Real-Time Price · USD
29.35
-0.19 (-0.64%)
At close: Aug 15, 2025, 3:45 PM

Astrana Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.03B 1.39B 1.14B 773.91M
Cost of Revenue
1.76B 1.17B 944.68M 596.14M
Gross Profit
271.39M 214.96M 199.48M 177.77M
Operating Income
89.35M 84.61M 104.27M 98.18M
Interest Income
14.51M 14.21M 1.98M 1.57M
Pretax Income
80.82M 89.84M 86.62M 77.75M
Net Income
43.15M 60.72M 45.17M 68.92M
Selling & General & Admin
154.11M 112.6M 77.67M 62.08M
Research & Development
n/a n/a n/a n/a
Other Expenses
27.93M 17.75M 17.54M 17.52M
Operating Expenses
182.04M 130.34M 95.21M 79.59M
Interest Expense
33.1M 16.1M 7.92M 5.39M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
1.95B 1.3B 1.04B 675.74M
Income Tax Expense
30.89M 31.99M 40.88M 31.69M
Shares Outstanding (Basic)
47.69M 46.71M 44.97M 43.83M
Shares Outstanding (Diluted)
48.22M 47.07M 45.6M 45.4M
EPS (Basic)
0.91 1.30 1.00 1.57
EPS (Diluted)
0.90 1.29 0.99 1.52
EBITDA
141.84M 123.69M 112.08M 100.66M
EBIT
113.92M 105.94M 94.54M 83.14M
Depreciation & Amortization
27.93M 17.75M 17.54M 17.52M